НовостиBenzingaJupiter Neurosciences Doses First Participant In Its Phase 2a RESET Clinical Study Of JOTROL To Treat Parkinson's Disease Jupiter Neurosciences Doses First Participant In Its Phase 2a RESET Clinical Study Of JOTROL To Treat Parkinson's Disease Benzinga 2026.10.06 15:18 (GMT+0) Открыть на Benzinga Другие новости